Carbon, a leader in 3D printing technology, today announced that its platform for bioresorbable elastomers, currently in development, has proven its biocompatibility in vivo[1]. All samples were found to be non-toxic and have a controllable absorption time. This latest milestone demonstrates the potential of the elastomer for the development of biomedical mesh applications such as soft tissue repair, wound dressings and nerve conduits.
Deutsch (Germany)
Polski (PL) 